SOLICITATION NOTICE
B -- Special Studies & Analysis / H5N1 - Package #1
- Notice Date
- 6/20/2011
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, Maryland, 20817
- ZIP Code
- 20817
- Solicitation Number
- NIAID-NOI-11117
- Archive Date
- 7/20/2011
- Point of Contact
- Jennifer Walker, Phone: 301-402-2282, Tonia L Alexander, Phone: 301-402-2282
- E-Mail Address
-
jewalker@niaid.nih.gov, talexander@niaid.nih.gov
(jewalker@niaid.nih.gov, talexander@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Statement of Work This is a combined Synopsis/Solicitation/Notice of Intent for commercial items prepared in accordance with the format of FAR Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are not being requested, and a written solicitation will not be issued for the solicitation number NIAID-NOI-11117 a Notice of Intent. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC2005-52, dated May 31, 2011. This acquisition will be processed under Simplified Acquisition Procedures (SAP) and is not a small business set-aside. The associated North American Industry Classification System (NAICS) Code is 541380, which has a size standard of 12 million dollars. The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure services in the field of clinical study and evaluation of an inactivated H5N1 influenza vaccine clinical trial on a sole source basis from Southern Research Institute, Birmingham, Alabama. The study is to evaluate the ability of the live attenuated H5N1 vaccines to prime for a robust immune response to vaccination with the non-adjuvanted H5N1 influenza vaccine that is licensed in the United States for adults who are at increased risk of exposure to H5N1 influenza virus. Subjects from the earlier studies of live attenuated pandemic influenza vaccines will be recalled to receive the inactivated H5N1 vaccine and immune responses will be measured by a variety of assays. The Offeror shall perform an assessment of an H5N1 influenza specific antibody response to be conducted over the time period of 2011 - 2012. Perform H5N1-specific hemagglutination inhibition (HAI) and microneutralization (MN) assays on the approximately 300 serum samples provided by ERVS. The assays will be conducted against the A/Vietnam/1203/2004 and related (H5N1) viruses. The viruses will be provided by ERVS, NIAID. The Offeror shall report the results within six (6) to twelve (12) months of the receipt of the serum samples. The report shall be provided in an Excel spreadsheet format that will include relevant positive and negative controls. Specifically, the Offeror shall do the following: 1) Perform HAI assays on no more than 600 serum samples and MN assays on no more than 300 serum samples. All assays will be conducted against the A/VN/1203/2004 (H5N1) influenza virus and will be non-GLP. Results shall be reported in an Excel spreadsheet only (no formal report will be issued). 2) The Project Officer will provide the serum samples to the Offeror at no cost to the Offeror. The Project Officer will provide written directions as to the return or disposition of any remaining material within 60 days of receipt of the results. See the attached Statement of Work. Performance shall be for twelve (12) months after receipt of order. Award will be based on meeting the following: 1) capability to meet required specifications, 2) price, 3) past performance, and 4) delivery. The FOB point shall be Destination. Place of delivery Bethesda, Maryland, 20892. This will be a firm-fixed price contract. The following Federal Acquisition Regulations provisions and clauses apply to the acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items; Far 52.212-2 Evalutaion Commercial Items; Far 52.212-3 Offeror Representation and Certifications Commercial Items; Far 52.212-4 Contract Terms and Conditions Commercial Items; Far 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items; and FAR 52.232-33, Payment by Electronic Funds Transfer-Central Contractor Registration (Oct 2003). A completed copy of provisions at FAR 52.212-3 Offerors Representation and Certifications Commercial Items must be included which can be found at Online Representations and Certifications Application (ORCA) https://orca.bpn.gov. By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the CCR database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. The CCR website is http://www/ccr.gov. [Note: Lack of registration in the Central Contractor Registration will make an offeror ineligible for award.] Copies of the aforementioned clauses are available upon request by telephone to Jennifer Walker at (301) 402-2282. All responsible sources may submit offers that will be considered by this agency. Offers must be submitted no later than 5:00 p.m. Eastern Standard Time (EST), July 5, 2011. For delivery through the U.S. Postal Service, the address is NIH/NIAID/AMOB, 10401 Fernwood Road, Room 2NE38A, Bethesda, MD, 20892-4811. Email and fax submissions are not acceptable. Requests for information concerning this requirement are to be addressed to Jennifer Walker at 301-402-2282. Collect calls will not be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/NIAID-NOI-11117/listing.html)
- Place of Performance
- Address: National Institutes of Health, NIAID, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN02476930-W 20110622/110620234523-7fb03c7c498eaddae936832585c7cb7f (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |